Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancerLisa H Butterfield, Antoni Ribas, Wilson S Meng, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Enhanced tumor responses to dendritic cells in the absence of CD8-positive cellsAntoni Ribas, Jennifer A Wargo, Begonya Comin-Anduix, et al.Immunology|November 24, 2004
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cellsShikhar Mehrotra, Arvind Chhabra, Abolokita Chakraborty, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.American Journal of Ophthalmology|April 17, 2007
Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanomaBradley R Straatsma, Steven Nusinowitz, Tara A Young, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humansRong Rong Huang, Jason Jalil, James S Economou, et al.Clinical Immunology (Orlando, Fla.)|June 16, 2010
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroSwagatam Ray, Arvind Chhabra, Nitya G Chakraborty, et al.Pageof 5